(Q51386908)

4 April 2018

title

Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients. (English)

1 reference

4 April 2018

0 references

1

1 reference

4 April 2018

Pamela Maffioli

2

1 reference

4 April 2018

Angela D'Angelo

4

1 reference

4 April 2018

Elena Fogari

5

1 reference

4 April 2018

Arrigo F. Cicero

8

1 reference

4 April 2018

Ilaria Ferrari

3

object named as

Ilaria Ferrari

1 reference

4 April 2018

Ilaria Palumbo

6

object named as

Ilaria Palumbo

1 reference

4 April 2018

Sabrina Randazzo

7

object named as

Sabrina Randazzo

1 reference

4 April 2018

publication date

16 November 2010

1 reference

4 April 2018

Fundamental and Clinical Pharmacology

published in

1 reference

4 April 2018

volume

25

1 reference

4 April 2018

issue

5

1 reference

4 April 2018

page(s)

642-651

1 reference

4 April 2018

The obesity paradox: impact of obesity on the prevalence and prognosis of cardiovascular diseases

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Weight management and current options in pharmacotherapy: orlistat and sibutramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Cardiomyopathy and carnitine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

The Glycosylation of Hemoglobin: Relevance to Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Determination of total serum insulin (IRI) in insulin-treated diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Use and abuse of HOMA modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Effect of the orlistat on serum endotoxin lipopolysaccharide and adipocytokines in South Asian individuals with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Obesity wars: molecular progress confronts an expanding epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

The role of TNFalpha and TNF receptors in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Neuroendocrine and metabolic effects of adipocyte-derived hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1472-8206.2010.00888.X

10.1111/J.1472-8206.2010.00888.X

21 January 2018

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018